BERTINARIA, Massimo
 Distribuzione geografica
Continente #
EU - Europa 4297
NA - Nord America 2390
AS - Asia 1564
AF - Africa 150
SA - Sud America 78
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 12
Totale 8546
Nazione #
DE - Germania 2639
US - Stati Uniti d'America 2269
CN - Cina 659
IT - Italia 473
GB - Regno Unito 327
IN - India 192
KR - Corea 177
CZ - Repubblica Ceca 137
RU - Federazione Russa 137
JP - Giappone 104
CA - Canada 92
VN - Vietnam 78
FR - Francia 75
NL - Olanda 66
ID - Indonesia 55
BR - Brasile 52
ES - Italia 47
IR - Iran 47
AU - Australia 44
PL - Polonia 38
TW - Taiwan 38
UA - Ucraina 36
HK - Hong Kong 35
ZA - Sudafrica 34
RO - Romania 31
MY - Malesia 30
BE - Belgio 29
AT - Austria 28
PT - Portogallo 26
EG - Egitto 24
IE - Irlanda 24
SE - Svezia 24
TH - Thailandia 24
MX - Messico 23
TR - Turchia 23
CH - Svizzera 20
NG - Nigeria 19
IL - Israele 18
DZ - Algeria 17
GR - Grecia 16
DK - Danimarca 14
ET - Etiopia 14
HU - Ungheria 14
PK - Pakistan 14
AL - Albania 13
FI - Finlandia 13
IQ - Iraq 12
LT - Lituania 12
MA - Marocco 11
NZ - Nuova Zelanda 11
MK - Macedonia 10
RS - Serbia 9
EU - Europa 8
NO - Norvegia 8
SA - Arabia Saudita 8
CL - Cile 7
SG - Singapore 7
SK - Slovacchia (Repubblica Slovacca) 7
AR - Argentina 6
CO - Colombia 6
GH - Ghana 6
HR - Croazia 6
SY - Repubblica araba siriana 5
TN - Tunisia 5
A1 - ???statistics.table.value.countryCode.A1??? 4
BG - Bulgaria 4
JO - Giordania 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
SI - Slovenia 4
AM - Armenia 3
BW - Botswana 3
CY - Cipro 3
LR - Liberia 3
MC - Monaco 3
MM - Myanmar 3
OM - Oman 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
EC - Ecuador 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
PE - Perù 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
IS - Islanda 1
Totale 8535
Città #
Nürnberg 252
Houston 197
Ann Arbor 140
Fairfield 134
Beijing 130
Torino 121
Santa Cruz 118
Woodbridge 100
Leawood 95
Buffalo 82
Wilmington 74
Seattle 72
Guangzhou 70
Ashburn 68
Seongnam 66
Dong Ket 59
Wuhan 57
Cambridge 56
Shanghai 47
Nanjing 44
Hangzhou 36
Jakarta 36
University Park 35
Jinan 33
Shenyang 31
Rome 30
Los Angeles 28
Hyderabad 27
Bedford 26
San Diego 26
Ottawa 24
Taipei 24
Pisa 23
Dublin 22
Seoul 22
Warsaw 22
Fleming Island 21
Duncan 20
Tokyo 20
Boston 19
Mountain View 19
Phoenix 19
Chengdu 18
Madrid 18
Milan 17
Moscow 17
Vienna 17
Las Vegas 16
New York 16
Chicago 15
Toronto 15
San Jose 14
Melbourne 13
Bengaluru 12
Helsinki 12
London 12
Nottingham 12
Zhengzhou 12
Bangkok 11
Dallas 11
Lake Forest 11
Turin 11
Central 10
Cincinnati 10
Costa Mesa 10
Hartford 10
Manchester 10
Council Bluffs 9
Easton 9
Florence 9
Fuzhou 9
Hefei 9
Kolkata 9
São Paulo 9
Xian 9
Berlin 8
Boardman 8
Central District 8
Chongqing 8
Clearwater 8
Kuala Lumpur 8
Munich 8
Tacoma 8
Tiranë 8
Waltham 8
Bonn 7
Dearborn 7
Earlysville 7
Hanoi 7
Liège 7
New Delhi 7
Newcastle upon Tyne 7
Osaka 7
Pretoria 7
Richmond 7
San Francisco 7
San Mateo 7
Shirokane 7
Tettnang 7
Bangalore 6
Totale 3131
Nome #
EXPLORING THE AMYLOID BETA (ABETA) DEPENDENT METABOLIC FINGERPRINT OF HIPPOCAMPAL NEURONS BY TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY: POTENTIALS IN DRUG DISCOVERY STUDIES, file e27ce426-f62c-2581-e053-d805fe0acbaa 2773
Development of covalent NLRP3 inflammasome inhibitors: chemistry and biological activity, file e27ce42f-1c04-2581-e053-d805fe0acbaa 582
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition, file e27ce428-5e9e-2581-e053-d805fe0acbaa 557
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY, file e27ce42f-32eb-2581-e053-d805fe0acbaa 445
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation, file e27ce42c-b04b-2581-e053-d805fe0acbaa 442
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria, file e27ce427-b4cc-2581-e053-d805fe0acbaa 370
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases, file e27ce42f-0b4e-2581-e053-d805fe0acbaa 253
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria, file e27ce426-bdc3-2581-e053-d805fe0acbaa 235
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile, file e27ce426-ead8-2581-e053-d805fe0acbaa 225
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties, file e27ce426-aadd-2581-e053-d805fe0acbaa 224
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis, file e27ce427-0bb3-2581-e053-d805fe0acbaa 207
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways, file e27ce42b-3243-2581-e053-d805fe0acbaa 193
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury?, file e27ce428-be85-2581-e053-d805fe0acbaa 171
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis, file e27ce42c-cfbd-2581-e053-d805fe0acbaa 147
In silico study of NLRP3: towards selective inhibition with small molecules, file e27ce42f-1c08-2581-e053-d805fe0acbaa 136
Edaravone derivatives containing NO-donor functions, file e27ce426-bc77-2581-e053-d805fe0acbaa 130
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation, file e27ce42d-984c-2581-e053-d805fe0acbaa 115
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile, file e27ce427-548c-2581-e053-d805fe0acbaa 103
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents, file e27ce426-c650-2581-e053-d805fe0acbaa 98
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation, file e27ce42c-8ce9-2581-e053-d805fe0acbaa 96
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors, file e27ce42b-688b-2581-e053-d805fe0acbaa 85
Synthesis of Small Molecules as Potential DNA Methylation Modulators, file e27ce428-513c-2581-e053-d805fe0acbaa 83
Do P2Y12 receptor antagonism and NLRP3 inhibition exert additive cardioprotective effects against ischemia/reperfusion injury?, file e27ce430-423e-2581-e053-d805fe0acbaa 79
Targeting of NLRP3 Inflammasome With a Novel Selective Inhibitor as a Suitable Strategy for the Pharmacological Treatment of Bowel Inflammation, file e27ce42c-dbdf-2581-e053-d805fe0acbaa 74
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold, file 08889351-65f4-45f0-9414-657c773f233e 73
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades, file e27ce430-3d0d-2581-e053-d805fe0acbaa 68
Nonsteroidal anti-inflammatory drugs: Exploiting bivalent COXIB/TP antagonists for the control of cardiovascular risk, file e27ce42e-e6ca-2581-e053-d805fe0acbaa 67
Design and synthesis of encorafenib-based BRAF-V600E degraders, file d8e03593-a5c7-4f96-9d2b-d9bc3af47ed2 65
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives, file e27ce427-b6d0-2581-e053-d805fe0acbaa 58
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor, file e27ce432-3ce7-2581-e053-d805fe0acbaa 57
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity, file e27ce426-b440-2581-e053-d805fe0acbaa 55
Edaravone derivatives containing NO-donor functions, file e27ce426-bc79-2581-e053-d805fe0acbaa 50
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors., file e27ce427-b2ad-2581-e053-d805fe0acbaa 47
Design and synthesis of SWIR emitters for optical imaging, file a3c77925-a20a-4f10-b791-18737969052f 41
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7, file e27ce432-52fe-2581-e053-d805fe0acbaa 39
Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors, file e27ce42b-8f91-2581-e053-d805fe0acbaa 37
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents, file e27ce426-df67-2581-e053-d805fe0acbaa 32
New tools for the development of direct NLRP3 inflammasome inhibitors, file e27ce42d-016a-2581-e053-d805fe0acbaa 32
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study, file e27ce434-a776-2581-e053-d805fe0acbaa 32
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs?, file e27ce427-1b40-2581-e053-d805fe0acbaa 31
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity, file e27ce42e-c9c8-2581-e053-d805fe0acbaa 30
Inflammasome Inhibitors, file e27ce434-47a9-2581-e053-d805fe0acbaa 30
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades, file e27ce430-279f-2581-e053-d805fe0acbaa 28
Editorial: Neurological, Metabolic and Inflammatory Disorders: A Common Root in Inflammasome, file e27ce434-47b6-2581-e053-d805fe0acbaa 25
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease, file e27ce42b-95d4-2581-e053-d805fe0acbaa 23
Synthesis and preliminary evaluation of model compounds targeting the NLRP3 inflammasome pathways, file e27ce427-0659-2581-e053-d805fe0acbaa 21
Pharmacological characterization of new NLRP3 inflammasome inhibitors., file e27ce430-5aa6-2581-e053-d805fe0acbaa 14
EVALUATION OF THE ANTIPYROPTOTIC ACTIVITY OF NEW INFLAMMASOME INHIBITORS, file e27ce434-886b-2581-e053-d805fe0acbaa 14
Targeting NLRP3 inflammasome regulatory mechanisms: design of anti-pyroptotic compounds for autoinflammatory diseases, file e27ce427-065a-2581-e053-d805fe0acbaa 5
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation, file e27ce42c-abc8-2581-e053-d805fe0acbaa 5
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein, file d8cded6f-e57e-4e8c-87da-877e19c5510e 4
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis, file e27ce427-0bb4-2581-e053-d805fe0acbaa 4
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile, file e27ce426-ead9-2581-e053-d805fe0acbaa 3
Do P2Y12 receptor antagonism and NLRP3 inhibition exert additive cardioprotective effects against ischemia/reperfusion injury?, file cafe8efa-2599-48b6-80d5-0c27d508951f 2
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols, file e27ce426-b041-2581-e053-d805fe0acbaa 2
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria, file e27ce426-bdc4-2581-e053-d805fe0acbaa 2
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents, file e27ce426-c64f-2581-e053-d805fe0acbaa 2
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents, file e27ce426-df66-2581-e053-d805fe0acbaa 2
Use of the Morita-Baylis-Hillman reaction in the design of compounds inhibiting NLRP3 inflammasome signaling pathways, file e27ce427-00af-2581-e053-d805fe0acbaa 2
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors., file e27ce427-bb7a-2581-e053-d805fe0acbaa 2
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition, file e27ce428-58dd-2581-e053-d805fe0acbaa 2
Nonsteroidal anti-inflammatory drugs: Exploiting bivalent COXIB/TP antagonists for the control of cardiovascular risk, file e27ce42c-810d-2581-e053-d805fe0acbaa 2
Nonsteroidal anti-inflammatory drugs: Exploiting bivalent COXIB/TP antagonists for the control of cardiovascular risk, file e27ce42c-810e-2581-e053-d805fe0acbaa 2
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria, file e27ce433-5823-2581-e053-d805fe0acbaa 2
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity, file e27ce426-b43f-2581-e053-d805fe0acbaa 1
Amphiphilic NO-Donor Antioxidants, file e27ce426-b66a-2581-e053-d805fe0acbaa 1
Edaravone derivatives containing NO-donor functions, file e27ce426-bc76-2581-e053-d805fe0acbaa 1
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives, file e27ce427-c541-2581-e053-d805fe0acbaa 1
Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors, file e27ce42a-87e8-2581-e053-d805fe0acbaa 1
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria, file e27ce42a-8cbe-2581-e053-d805fe0acbaa 1
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors, file e27ce42a-a55c-2581-e053-d805fe0acbaa 1
Totale 8842
Categoria #
all - tutte 10291
article - articoli 0
book - libri 0
conference - conferenze 4700
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018354 0000 00 073 102833561
2018/20191139 784568102 7558 92140 110111158102
2019/20201804 111119132114 133203 201152 162154172151
2020/20211475 103147126120 148125 14793 110111103142
2021/20221385 12610289161 12368 109113 10784181122
2022/2023941 5496189186 94161 1529 0000
Totale 8842